Clinical Trials Logo

Adverse Drug Event clinical trials

View clinical trials related to Adverse Drug Event.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06244706 Not yet recruiting - Chronic Pain Clinical Trials

QSPainRelief-STRAT

QSPR-STRAT
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

Investigating the clinical outcomes of drug combinations (opioid + medication acting on the central nervous system) in patients suffering from persistent pain (pain lasting for at least three months) through patient-reported outcomes.

NCT ID: NCT04574648 Not yet recruiting - Adverse Drug Event Clinical Trials

Evaluating ActionADE on Adverse Drug Event Due to Non-Adherence

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Repeat non-adherence to medications is a common cause of preventable adverse drug events. Health information technologies have the potential to improve information continuity. However, they rarely interoperate to ensure providers can view non-adherence information documented in other systems. The investigators designed ActionADE to enable rapid documentation of adverse drug events, including non-adherence, and communicate the information across health sectors by integrating ActionADE with legacy systems. The investigators will leverage ActionADE's implementation to conduct a randomized trial on patients diagnosed with an adverse events due to non-adherence. This study will take place in Vancouver, British Columbia, Canada.

NCT ID: NCT04568668 Not yet recruiting - Adverse Drug Event Clinical Trials

Evaluating ActionADE in Reducing Adverse Drug Reactions

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Repeat exposures to culprit medications are a common cause of preventable adverse drug events. Health information technologies have the potential to reduce repeat adverse drug events by improving information continuity. However, they rarely interoperate to ensure providers can view adverse drug events documented in other systems. The investigators designed ActionADE to enable rapid documentation of adverse drug events, and communication of standardized information across health sectors by integrating ActionADE with legacy systems. The investigators will leverage ActionADE's implementation to conduct a randomized trial on patients diagnosed with adverse drug reactions in the main trial. This study will take place in Vancouver, British Columbia, Canada.

NCT ID: NCT04193839 Not yet recruiting - Adverse Drug Event Clinical Trials

Reducing Errors In The Neonatal Intensive Care Unit

SAPHET-i
Start date: January 1, 2020
Phase:
Study type: Observational [Patient Registry]

This is a monocentric prospective pre and post-intervention study, aiming at analyzing the efficacy of the Computerized Provider Order Entry (CPOE) plus Bar Code Medication Administration (BCMA) as compared to paper order entry in reducing medication erros (MEs) in the Neonatal Intensive Care Unit (NICU)